Osaic Holdings’s vTv Therapeutics VTVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.4K Sell
1,119
-1
-0.1% -$36 ﹤0.01% 5309
2025
Q4
$44.8K Sell
1,120
-500
-31% -$13.9K ﹤0.01% 5306
2025
Q3
$37.2K Buy
1,620
+1,450
+853% +$25.4K ﹤0.01% 5505
2025
Q2
$2.55K Buy
170
+18
+12% +$330 ﹤0.01% 6848
2025
Q1
$2.63K Sell
152
-18
-11% -$301 ﹤0.01% 6486
2024
Q4
$2.35K Sell
170
-8
-4% -$118 ﹤0.01% 6543
2024
Q3
$2.41K Buy
178
+8
+5% +$133 ﹤0.01% 6539
2024
Q2
$3K Buy
170
+20
+13% +$477 ﹤0.01% 6423
2024
Q1
$3.53K Buy
150
+100
+200% +$1.27K ﹤0.01% 6238
2023
Q4
$575 Sell
50
-50
-50% -$702 ﹤0.01% 6873
2023
Q3
$1.91K Buy
100
+48
+92% +$1.17K ﹤0.01% 6643
2023
Q2
$1.52K Hold
52
﹤0.01% 6753
2023
Q1
$1.66K Hold
52
﹤0.01% 6793
2022
Q4
$1K Hold
52
﹤0.01% 6979
2022
Q3
$2K Hold
52
﹤0.01% 6849
2022
Q2
$2K Hold
52
﹤0.01% 6945
2022
Q1
$1K Hold
52
﹤0.01% 7129
2021
Q4
$2K Hold
52
﹤0.01% 7062
2021
Q3
$3K Sell
52
-37
-42% -$2.79K ﹤0.01% 6776
2021
Q2
$8K Buy
89
+39
+78% +$3.95K ﹤0.01% 6218
2021
Q1
$6K Hold
50
﹤0.01% 6098
2020
Q4
$4K Hold
50
﹤0.01% 5887
2020
Q3
$4K Hold
50
﹤0.01% 5666
2020
Q2
$5K Hold
50
﹤0.01% 5500
2020
Q1
$4K Buy
+50
New +$4.81K ﹤0.01% 5471

Other funds holding VTVT

Osaic Holdings's VTVT Position: Q1 2026 in Review

Osaic Holdings reduced its vTv Therapeutics (VTVT) stake by 0.09% in Q1 2026, selling an estimated $36 and leaving 1,119 shares worth $44.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5309.

Osaic Holdings first reported a position in VTVT in Q1 2020 and has held it in 25 quarters since. The position peaked at $44.8K in Q4 2025. 35 funds tracked by Wall St. Rank hold VTVT as of Q1 2026.

  • Osaic Holdings held 1,119 shares of vTv Therapeutics worth $44.4K as of Q1 2026.
  • Osaic Holdings sold 1 vTv Therapeutics share in Q1 2026, an estimated $36.
  • vTv Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5309 holding.
  • Osaic Holdings first reported a position in vTv Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's vTv Therapeutics position peaked at $44.8K in Q4 2025.
  • 35 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.